9^th World Congress On Cardiology and Heart Failure

Cardio-Oncology

Cardio-oncology is the intersection of heart failure conditions in patients who have been treated for cancer. New insights into however cancer therapies impact cardiovascular physiological condition and long-run effects on cancer survivors. In view of trends, similarly because the cardiovascular toxicity potential of radiation and therapy, cancer patients square measure exposed to vas morbidity and mortality over ever before. Anticancer therapies will cause important injury to the vasculature, leading to angina, acute coronary syndromes (ACS), stroke, critical limb ischemia, arrhythmias, and heart failure (HF), independently from the direct myocardial or pericardial damage that might occur. Moreover, cancer is mostly related to a hypercoagulable state, that will increase the danger of acute thrombotic events.